AdaptHealth (NASDAQ:AHCO) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen upgraded shares of AdaptHealth (NASDAQ:AHCOFree Report) from a buy rating to a strong-buy rating in a report published on Friday.

Several other equities analysts also recently issued reports on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of AdaptHealth in a report on Saturday, September 27th. Zacks Research cut shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Five investment analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the company. According to MarketBeat, AdaptHealth has a consensus rating of “Hold” and an average price target of $13.40.

View Our Latest Report on AHCO

AdaptHealth Stock Down 3.7%

Shares of NASDAQ AHCO opened at $9.09 on Friday. AdaptHealth has a 52-week low of $7.11 and a 52-week high of $11.63. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. The business has a fifty day moving average of $9.25 and a two-hundred day moving average of $9.12. The stock has a market cap of $1.23 billion, a PE ratio of 16.83, a PEG ratio of 1.05 and a beta of 1.61.

Insider Buying and Selling

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director owned 50,045 shares in the company, valued at approximately $486,937.85. The trade was a 14.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.55% of the company’s stock.

Institutional Investors Weigh In On AdaptHealth

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in AdaptHealth by 21.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 197,901 shares of the company’s stock worth $1,884,000 after purchasing an additional 35,431 shares during the period. GAMMA Investing LLC lifted its holdings in AdaptHealth by 2,883.7% during the first quarter. GAMMA Investing LLC now owns 81,007 shares of the company’s stock worth $878,000 after acquiring an additional 78,292 shares in the last quarter. Reinhart Partners LLC. lifted its holdings in AdaptHealth by 15.5% during the first quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company’s stock worth $78,441,000 after acquiring an additional 969,408 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in AdaptHealth by 23.5% in the first quarter. Harbor Capital Advisors Inc. now owns 586,443 shares of the company’s stock valued at $6,357,000 after acquiring an additional 111,721 shares during the period. Finally, SummerHaven Investment Management LLC raised its position in shares of AdaptHealth by 1.7% during the first quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company’s stock worth $866,000 after purchasing an additional 1,329 shares during the period. Institutional investors own 82.67% of the company’s stock.

About AdaptHealth

(Get Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

See Also

Analyst Recommendations for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.